Modifiable Risk Factors, Plasma Proteomics, and Risks of Major Adverse Cardiovascular Events Among Individuals With Type 2 Diabetes

Modifiable Risk Factors, Plasma Proteomics, and Risks of Major Adverse Cardiovascular Events Among Individuals With Type 2 Diabetes

Saved in:

Bibliographic Details
Main Authors:	Ruyi Li, Shufan Tian, Yunfei Liao, An Pan, Gang Liu
Format:	Article
Language:	English
Published:	Elsevier 2025-05-01
Series:	Current Developments in Nutrition
Online Access:	http://www.sciencedirect.com/science/article/pii/S2475299125025065
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Clinical researchs and advances of risk factors for major cardiovascular adverse events in patients with chronic kidney diseases
by: Li Jin-long, et al.
Published: (2022-11-01)

Sleep disorder is associated with increased risk of major adverse cardiovascular events in patients with schizophrenia
by: Jinbo Wu, et al.
Published: (2025-07-01)

Improved prediction and risk stratification of major adverse cardiovascular events using an explainable machine learning approach combining plasma biomarkers and traditional risk factors
by: Xi-Ru Zhang, et al.
Published: (2025-04-01)

Body mass index modifies the major adverse cardiovascular and cerebral events risk of NT-proBNP in patients with acute coronary syndrome
by: Xiaoquan He, et al.
Published: (2025-03-01)

Renal hyperfiltration as risk factor of major adverse cardiovascular events in patients with acute myocardial infarction
by: Jin Sug Kim, et al.
Published: (2025-07-01)

Biological use influences the impact of inflammation on risk of major adverse cardiovascular events in rheumatoid arthritis
by: George Athanasios Karpouzas, et al.
Published: (2024-09-01)

Triglyceride-Glucose Index Predicts Major Adverse Cardiovascular and Cerebrovascular Events in Non-Diabetic Individuals
by: Cangtuo Li, et al.
Published: (2025-07-01)

Construction and Comparison of Machine Learning-Based Risk Prediction Models for Major Adverse Cardiovascular Events in Perimenopausal Women
by: Chen A, et al.
Published: (2025-01-01)

Effect of levothyroxine on major adverse cardiovascular events in patients with hypothyroidism and cardiovascular disease
by: Lijia Liu, et al.
Published: (2025-08-01)

Association between the atherogenic index of plasma and major adverse cardiovascular events in patients with premature coronary artery disease
by: Xiangzhen Ran, et al.
Published: (2025-06-01)

Eosinophil counts predict 3-year risk of major adverse cardiovascular and cerebrovascular events in carotid artery stenosis patients
by: Ruijing Zhang, et al.
Published: (2025-07-01)

Frailty, Pitavastatin, and Major Adverse Cardiovascular Events Among People With HIV
by: Kristine M. Erlandson, MD, MS, et al.
Published: (2025-09-01)

Metabolic syndrome with mortality and major adverse cardiovascular events in an elderly population
by: Shailendra Kumar Karn, et al.
Published: (2025-05-01)

Association of short-term air pollution with risk of major adverse cardiovascular event mortality and modification effects of lifestyle in Chinese adults
by: Wendi Xiao, et al.
Published: (2025-05-01)

Ten-year predictors of major adverse cardiovascular events in patients without angina
by: Preesha Premsagar, et al.
Published: (2023-08-01)

Validation of Medication Proxies for the Identification of Hospitalizations for Major Adverse Cerebro-Cardiovascular Events
by: Steenhuis D, et al.
Published: (2025-03-01)

Major Adverse Cardiovascular Events in Patients with Melanoma Receiving Immune Checkpoint Inhibitors
by: Juan I. Ruiz, et al.
Published: (2025-04-01)

Major Adverse Cardiovascular Events and Cause-Specific Mortality After Hospitalisation in COPD
by: Ioannides AE, et al.
Published: (2025-07-01)

The Relationship Between Quantitative Ischemia, Early Revascularization, and Major Adverse Cardiovascular Events
by: Robert JH. Miller, MD, et al.
Published: (2025-01-01)

Combining echocardiography with carotid ultrasound parameters in predicting major adverse cardiovascular events among older individuals with coronary artery disease
by: Tianli Jia, et al.
Published: (2025-07-01)

Sex differences in 5-year risk of major adverse cardiovascular events in patients with coronary artery disease and elevated lipoprotein(a) levels
by: R. B. Alieva, et al.
Published: (2025-04-01)

Using the RISK-PCI Score in the Long-Term Prediction of Major Adverse Cardiovascular Events and Mortality after Primary Percutaneous Coronary Intervention
by: Lidija Savic, et al.
Published: (2019-01-01)

Distinctive blood and salivary proteomics signatures in Qatari individuals at high risk for cardiovascular disease
by: Ghada Yousif, et al.
Published: (2025-02-01)

Prediction of 1-Year Major Adverse Cardiovascular Events in Chronic Limb Threatening Ischemia
by: Sreekanth Vemulapalli, MD, et al.
Published: (2025-08-01)

Establishment of a prediction model for major adverse cardiovascular and cerebrovascular events in prehypertensive patients
by: HE Zhi,an，LAI Jiangqiong，ZHENG Tao
Published: (2025-07-01)

CHADS2 Scores in the Prediction of Major Adverse Cardiovascular Events in Patients with Cushing’s Syndrome
by: Yuh-Feng Wang, et al.
Published: (2014-01-01)

Vascular dysfunction is associated with major adverse cardiovascular events in prediabetes: A cohort study
by: Dariya Kozlova, et al.
Published: (2025-01-01)

Relationship Between the Drop Rate of Standing Blood Pressure and Major Adverse Cardiovascular Events
by: Wenqin Cai, et al.
Published: (2025-05-01)

Urinary albumin-to-creatinine ratio in patients with hypertension and risk of major cardiovascular events
by: Morten Schou, et al.
Published: (2025-05-01)

A Systematic Review of risk factors for major adverse cardiovascular events in patients with coronary heart disease who underwent percutaneous coronary intervention
by: You Zhai, et al.
Published: (2025-04-01)

Development and validation of an in-hospital major adverse cardiovascular events risk model for young patients with acute coronary syndrome: a retrospective cohort study
by: Jia Zheng, et al.
Published: (2025-05-01)

Plasma proteomic signatures as predictors of dementia risk in individuals with sleep apnea: a cohort study
by: Yufei Liu, et al.
Published: (2025-05-01)

Estimated potassium intake and major adverse cardiovascular events in individuals with type 2 diabetes: a prospective cohort study with trans-ethnic validation
by: Jian-Jun Liu, et al.
Published: (2024-12-01)

A multitask deep learning model utilizing electrocardiograms for major cardiovascular adverse events prediction
by: Ching-Heng Lin, et al.
Published: (2025-01-01)

Patient Demographics and Major Adverse Cardiovascular Events after Androgen Deprivation Therapy for Prostate Cancer
by: Christopher J. D. Wallis, et al.
Published: (2024-01-01)

Predictors of Major Adverse Cardiovascular Events in Stable Patients After ST Elevation Myocardial Infarction
by: Lidija Savic, et al.
Published: (2025-05-01)

Blood pressure variability is associated with major adverse cardiovascular events in patients on maintenance peritoneal dialysis
by: XU Guang, et al.
Published: (2019-01-01)

Coronary Plaque, Inflammation, Subclinical Myocardial Injury, and Major Adverse Cardiovascular Events in the REPRIEVE Substudy
by: Michael T. Lu, MD, MPH, et al.
Published: (2025-06-01)

Association between residual cholesterol and vulnerable non-culprit lesions progressing to major adverse cardiovascular events
by: Fengfeng Wang, et al.
Published: (2025-08-01)

Cardiac scoring systems, coronary artery disease and major adverse cardiovascular events: A scoping review
by: Preesha Premsagar, et al.
Published: (2023-08-01)